Amyotrophic lateral sclerosis (ALS) is a progressive and always fatal neurodegenerative disorder that in volves death of motor neurons in the spinal cord. Analy ses of cerebrospinal fluid and postmortem spinal cord tissue from ALS patients have demonstrated increased levels of oxidative stress (lipid peroxidation and protein oxidation), (Beal et aI., 1997; Ferrante et al., 1997a; Ped ersen et al., 1998) , increased levels of extracellular glu tamate, and reduced levels of glutamate transporters (see Rothstein, 1995 for review), in ALS patients. Although the cause of most cases of ALS is unknown, some cases result from heritable mutations in Cu/Zn-SOD (Gurney et a!., 1996) . The Cu/Zn-SOD mutations do not compro mise the normal dismutase activity of the enzyme but glucose and glutamate transport in cerebral cortex synaptic ter minals were markedly decreased, and levels of membrane lipid peroxidation were increased in Cu/Zn-SOD mutant mice com parcd to nontransgenic mice. These findings demonstrate that mutant Cu/Zn-SOD may endanger brain neurons by a mecha nism involving impairment of glucose and glutamate transport ers. Moreover, our data demonstrate a direct adverse effect of the mutant enzyme on synaptic function. Key Words: Amyo trophic lateral sclerosis-Excitotoxicity-Focal ischemia Lipid peroxidation-Transgenic.
instead result in gain of an adverse property of the mu tant protein which may involve increased peroxidase ac tivity resulting in hydroxyl radical production (Wiedau Pazos et a!., 1996; Yim et al., 1997) . Expression of ALS linked Cu/Zn-SOD mutations in transgenic mice results in progressive degeneration of spinal cord motor neurons and associated paralysis (Gurney et a!., 1994; Wong et al., 1995) . Studies of spinal cord motor neurons from the ALS mice in cell culture and in vivo have provided evi dence that the Cu/Zn-SOD mutations result in increased levels of oxidative stress and increased vulnerability to excitotoxicity (Ferrante et a1., 1997 b; Siklos et aI., 1998; Roy et al., 1998; Krllman et al., 1999) . The pathogenic action of Cu/Zn-SOD mutations in familial ALS does not result from a loss of dismutase function of the enzyme, but rather from gain of an adverse property of the mutant protein. Thus, there is no correlation between enzyme activity and disease severity in ALS patients and Cu/Zn SOD mutant mice, and enzyme activity appears to be increased consistent with the level of enzyme overex pression (Gurney et al., 1994; Ripps et al., 1995; Wong et al., 1995) . Moreover, Cu/Zn-SOD knockout mice are viable, live well beyond I year of age, and fail to develop motor neuron disease (Reaume et aI., 1996) . The specific alteration in the mutant enzyme has not been established but might result from enhanced hydroxyl radical produc tion compared with the wild-type protein (Wiedau-Pazos et aI., 1996; Yim et aI., 1997) .
Oxidative stress, impaired energy metabolism, and overactivation of glutamate receptors are increasingly implicated in the pathogenesis of neurodegenerative dis orders ranging from Alzheimer's and Parkinson's dis eases (Mattson, 1997; Jenner and Olanow, 1998) to stroke (Chan, 1996) . Because glutamate receptors are concentrated in postsynaptic terminals, the excitotoxic process (be it apoptosis or necrosis) is initiated in syn aptic compartments and propagates to the cell body (Mattson et aI., 1998; Duan et aI., 1999) . Oxidative stress and lipid peroxidation can impair the function of gluta mate and glucose transporters (Keller et aI., 1997a; Mark et aI., 1997a; Blanc et aI., 1998) and ion-motive ATPases (Mark et aI., 1995 (Mark et aI., , 1997b in neuronal cultures and syn aptosome preparations. Impairment of these transporters results in increased levels of extracellular glutamate, ATP depletion and membrane depolarization, and exces sive influx of calcium through N-methyl-D-aspartate re ceptors and voltage-dependent channels.
Metabolic and oxidative alterations in neurodegenera tive disorders are often not limited to the neuronal popu lations that ultimately succumb (see Govoni et aI., 1996; Connolly, 1998; Schapira et aI., 1998 for review) . A few studies suggest that abnormalities in ALS are not limited to the spinal cord. For example, positron emission to mography studies of cerebral glucose utilization have documented reduced levels of glucose uptake throughout many regions of cerebral cortex of ALS patients (Lu dolph et aI., 1992) . Levels of glutamate transport proteins are decreased in cerebral cortex of ALS patients (Roth stein et aI., 1995) , and ALS patients exhibit abnormali ties in carbohydrate metabolism (Murai et aI., 1983) . It is not known whether such abnormalities precede motor neuron degeneration or are secondary phenomena. In the present study we directly tested the hypothesis that ab normalities are present in the brains of Cu/Zn-SOD transgenic mice before onset of motor dysfunction and that such alterations place the neurons "at risk." We re port that synaptic glucose and glutamate transport are impaired in cerebral cortex of the ALS mice and that these abnormalities are associated with increased vulner ability to ischemic injury.
MATERIALS AND METHODS

Mice and transient focal cerebral ischemia protocol
Transgenic mice overexpressing human Cu/Zn-SOD with the ALS-linked G93A mutation (TgNlSODI-G93AllGur) were purchased from Jackson Laboratories (Bar Harbor, ME,
U.S.A.). Mice were maintained on a B6/SJL background, and transgenic and nontransgenic offspring of crosses of heterozy gous mice were used for experiments. Mice were maintained on a 12-hour light: 12-hour dark cycle and were provided free ac cess to food and water. Cu/Zn-SOD mutant mice used in the present study developed progressive lower motor neuron de generation and associated paralysis beginning from 5 to 7 months of age. All experiments were performed on 3-month old male mice. The protocol for performing focal cerebral isch emia using a middle cerebral artery occlusion-reperfusion method was similar to that used in our previous studies (Bruce et aI., 1996; Keller et ai., 1998) and was adapted from Huang et ai. (1994) . Briefly, mice were anesthetized with 350 mg/kg chloral hydrate. Thermistor probes were inserted into the rec tum and temporalis muscles to monitor body and brain tem perature, which were maintained at 36 to 3]oC by external warming. Blood samples were taken at baseline (10 minutes before occlusion), during ischemia (30 to 35 minutes after thread placement), and 10 minutes after reperfusion for mea surements of blood gases and pH level. The left common ca rotid artery was exposed and the occipital, superior thyroidal, maxi llary, and lingual branches of the external carotid artery were coagulated; the pterygopalatine artery was ligated. An incision was made in the external carotid artery and a polyly sine-coated suture was advanced into the middle cerebral ar tery. The thread was left in place for 60 minutes and then removed to allow reperfusion. After surgery mice were re turned to their cages and given free access to food and water. Neurologic deficits were assessed 22 hours after ischemia based on a scale from 0 (no deficits) to 3 (severe deficits) as described previously (Huang et aI., 1994; Endres et aI., 1999) . At 24 hours after ischemia the mice were euthanized by anes thesia overdose, and coronal brain sections (1 mm thick) were stained with 1 % triphenyltetrazolium chloride. Images of the stained brain slices were captured using a digital camera, and the infarct volume was quantified as described previously (Keller et ai., 1998) .
Synaptosome preparation and experimental treatment
Eight wild-type and 12 PS I mutant mice were used for these studies. For each synaptosome preparation, cerebral hemi spheres from 2 mice were pooled and homogenized in a solu tion containing 0.32 mollL sucrose, 4 f,Lg/mL pepstatin, 5 f,Lgl mL aprotinin, 20 f,Lg/mL trypsin inhibitor, 4 f,Lg/mL leupeptin, 0.2 mmollL phenyl-methylsulfonyl fluoride, 2 mmollL EDTA, 2 mmol/L EGT A, and 20 mmol/L Hepes. Synaptosomes were prepared using a sucrose density gradient protocol described in our previous studies (Keller et aI., 1997; Begley et ai., 1999) . Protein concentrations in synaptosomal preparations were de termined (Pierce BCA kit), and the synaptosomes were diluted in Locke's buffer (NaCI, 154 mmol/L; KCI, 5.6 mmollL; CaCI2, 2.3 mmollL; MgCI2, 1.0 mmol/L; NaHC03, 3.6 mmoll L; glucose, 5 mmol/L; Hepes, 5 mmollL; pH 7.2) to a final concentration of 200 f,Lg proteinimL. Synaptosomes were then aliquoted into 1.5-mL Eppendorf tubes for glucose and gluta mate transport assays or into wells of 96-well plates for mea surement of lipid peroxidation. Synaptosomes were either left untreated or were exposed to 10 f,LmollL FeS04.
Measurement of glucose and glutamate transport and lipid peroxidation
The methods for quantifying glutamate and glucose transport in synaptosomes have been described previously (Keller et aI., 1997) . For the glutamate uptake assay, synaptosomes (200 f,Lgl tube) were incubated for 7 minutes with eHl-glutamate (0.1 fLCi/mL). The synaptosomes were then pelleted, washed three times in Locke's buffer, and lysed in 200 fLL of solution of 1% sodium dodecyl sulfate in phosphate-buffered saline. The lysate was placed in scintillation vials containing Scintiverse, and radioactivity was counted in a Packard 2500TR liquid scintil lation counter. For the glucose uptake assay, synaptosomes (200 fLg/tube) were subjected to experimental treatments and then washed three times in glucose-free Locke's buffer, and the assay was started by the addition of 1.5 fLCi of ['Hl-2deoxyglucose. Seven minutes later the assay was stopped by pelleting the synaptosomes, washing twice with glucose-free Locke's solution, and lysing the synaptosomes in 200 fLL of a 1 % sodium dodecyl sulfate-phosphate-buffercd saline solution. The lysate was placed in scintillation vials containing Scinti verse, and radioactivity was counted in a Packard 2500TR liq uid scintillation counter. Results were expressed as counts per minute per milligram of protein. The rates of glucose and glu tamate uptake by synaptosomes remained constant under basal conditions throughout the time course of experiments (up to 4 hours). In such assays of glucose and glutamate transport there is often considerable interassay variability in terms of counts per minute of synaptosome-associated radioactivity, whereas intraassay variability is quite low. Because we always included control conditions within an experiment, the experimental val ues were compared directly to the control value within the experiment. Levels of membrane lipid peroxidation were as sessed using a thiobarbituric acid-reactive substances t1uores cence-based method described previously (Keller et ai., 1998) . Values were expressed as a percentage of the value in untreated synaptosomes from wild-type mice.
RESUL TS AND DISCUSSION
Previous studies have shown that in the same trans genic line of mice used in the present study, mutant Cu/Zn-SOD is expressed in cells throughout the nervous system, although levels of expression are somewhat lower in the brain as compared to the spinal cord (Liu et aI., 1998) . Our preliminary studies confirmed expression of the trans gene in cerebral cortical tissue, wherein levels of overall Cu/Zn-SOD enzyme activity were increased approximately 2-to 3-fold (data not shown). In order to determine whether mutant Cu/Zn-SOD affects the vul nerability of cortical neurons to injury induced by meta bolic/excitotoxic insults we subjected nontransgenic (wild-type) mice (n = 10) and Cu/Zn-SOD mutant mice (n = 10) to transient middle cerebral artery occlusion, a model of focal ischemic stroke. There were no signifi cant differences in physiologic parameters (mean arterial pressure; blood O2, CO2, pH, and glucose; cerebral blood flow) between wild-type and mutant mice at baseline, during ischemia, or after reperfusion (Table I) . Infarct volume, measured 24 hours after ischemia, was signifi cantly increased in Cu/Zn-SOD mutant mice compared to wild-type mice (Fig. I) . The increased brain damage in the mutant mice was associated with increased behav ioral deficits (Fig. I) . The increased vulnerability to focal ischemia-reperfusion injury in Cu/Zn-SOD mutant mice is apparently attributable to the mutation in the enzyme rather than to overexpression of the enzyme, because previous studies using the same ischemia-reperfusion Measurements were made 10 minutes before occlusion, during isch emia (10 minutes after occlusion), and 10 minutes after reperfusion (except for cerebral blood flow which was measured 30 minutes after reperfusion).
model have shown that transgenic mice overexpressing wild-type Cu/Zn-SOD exhibit decreased infarct size after focal ischemia (Yang et aI., 1994) . We observed no dif ferences in cerebral vascular anatomy, and because ce rebral blood flow was similar in mutant and nontrans genic mice (before, during, and after ischemia), indicat ing that mutant Cu/Zn-SOD did not affect vascular structure or physiology.
Ischemic neuronal injury involves ATP depletion, oxi dative stress, and overactivation of glutamate receptors which results in calcium overload, mitochondrial dys function, and either apoptosis or necrosis (see Chan, 1996; Mattson et aI., 1999 for review). To elucidate the mechanism(s) responsible for the endangering action of mutant Cu/Zn-SOD toward cortical neurons, we studied cortical synaptosomes from wild-type and Cu/Zn-SOD mutant mice. It was previously reported that levels of membrane lipid peroxidation are increased in spinal cords of ALS patients and Cu/Zn-SOD mutant mice (Hall et ai., 1998; Pedersen et ai., 1998) . Measurement of relative levels of membrane lipid peroxidation, using a thiobarbituric acid-reactive substances assay, revealed a small but significant increase in basal levels of lipid per oxidation in synaptosomes from transgenic mice com pared to wild-type mice ( Fig. 2A) . The magnitude of the increase in lipid peroxidation induced by Fe 2 + was also significantly increased in synaptosomes from the trans genic mice, suggesting an increased sensitivity to oxida tive stress.
We had previously shown that glucose and glutamate transport in cortical synaptosomes are impaired after ex posure to insults that induce membrane lipid peroxida tion (Keller et ai., 1997a,b) . Because impairment of glu cose and glutamate transport would be expected to ren der neurons vulnerable to excitotoxicity, we measured levels of glucose and glutamate transport in synapto somes from nontransgenic and transgenic mice. There was a striking 70% reduction in the level of glucose transport in synaptosomes from Cu/Zn-SOD mutant mice compared to wild-type mice (Fig. 2B) . The level of glutamate transport was also significantly reduced by approximately 40% in synaptosomes from Cu/Zn-SOD mutant mice (Fig. 2B) . In light of these findings and because we observed no differences in cerebral vascular anatomy and because cerebral blood t10w was similar in mutant and nontransgenic mice (before, during, and after ischemia), we conclude that the increased infarct size after focal ischemia-reperfusion in the the Cu/Zn-SOD mutant mice results from an adverse effect of the mutant enzyme in synaptic terminals of neurons. However, a contribution of indirect effects of the mutant enzyme on the vasculature or glial cells cannot be ruled out.
Previous studies have provided evidence that levels of oxidative stress are increased in cerebral cortex of ALS patients (Ferrante et ai., 1997 a) , and that levels of lipid peroxidation and protein nitration are increased in cere bral cortical tissue from transgenic mice expressing an ALS-linked Cu/Zn-SOD mutation (Ferrante et aI. , 1997 b) . The latter studies involved analyses of brain tis sue taken from end-stage ALS patients and Cu/Zn-SOD mutant mice. Our studies, performed on brain tissue taken several months before the onset of symptomatic motor dysfunction, suggest that cortical neurons are sub jected to increased oxidative stress during the early stages of the disease process. Measurements of lipid per oxidation in spinal cord tissue of Cu/Zn-SOD mutant mice (Hall et ai. , 1998) and motor neurons in cultures established from embryonic Cu/Zn-SOD mutant mice (Kruman et ai., 1999) also indicate that lipid peroxida tion occurs before motor neuron degeneration. We found striking deficits in glucose and glutamate transport in cortical synaptosomes from the Cu/Zn-SOD mutant mice suggesting that the neurons are subjected to metabolic and excitotoxic stress. Although the mechanism whereby mutant Cu/Zn-SOD causes impaired glucose and gluta mate transport is unknown, it might result from increased oxidative stress. Studies of hippocampal and cortical cell cultures and synaptosomes (Keller et ai., 1997a,b; , 1997a,b; Blanc et aI., 1998) and motor neuron-like cells (Pedersen et aI., 1999) have shown that membrane li p id p eroxidation results in impairment of glucose and glutamate transporters. In addition, mutant Cu/Zn-SOD was reported to inactivate the glutamate transporter GLT -1 (Trotti et aI., 1999) . The beneficial effect of an tioxidants, such as vitamin E that act by su pp ressing lipid p eroxidation in ALS mice (Gurney et aI., 1996) , is con sistent with a role for oxidative impairment of glucose and glutamate transport in the pathogenesis of ALS. Our findings may also provide an explanation for the wide s p read decrease in glucose utilization (Ludolph et aI. , 1992) and the decreased levels of glutamate transporter p rotein GL T -I (Rothstein et aI. , 1995) in cerebral cortex of ALS patients.
The demonstration of impaired glucose and glutamate trans p ort in cortical synaptosomes from Cu/Zn-SOD mu tant mice provides the first direct evidence for syna p tic dysfunction in ALS. Our findings support the excitotox icity hypothesis of ALS in that impaired glucose and glutamate transport in synaptic terminals would predis p ose neurons to excitotoxicity.
